Loading insider details...
Latest Form 4 (Jun 18, 2026): Grant/Award of 454 MDGL shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 18, 2026 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/Award | 454 | n/a |
| Mar 6, 2026 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Sale | 491 | $212.1K |
| Jan 26, 2026 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Sale | 647 | $318.6K |
| Jan 20, 2026 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Sale | 2,238 | $1.10M |
| Jan 13, 2026 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Exercise/Conversion | 240 | $3.8K |
| Jan 13, 2026 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Exercise/Conversion | 18,410 | $290.9K |
| Dec 12, 2025 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Exercise/Conversion | 18,650 | $294.7K |
| Aug 13, 2025 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Exercise/Conversion | 3,200 | $30.2K |
| Jul 22, 2025 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Exercise/Conversion | 1,000 | $9.4K |
| Jul 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Exercise/Conversion | 26,444 | $249.9K |